指南下载,课程观看,礼品兑换!积分不足怎么办?梅斯100积分免费领,解决您的积分困扰~

2022-07-21 网络 网络

【梅斯100积分限时领】活动

【梅斯100积分限时领】活动
手机微信添加下方好友,即可立即领取,没有任何条件限制,参与即可得
活动每人仅限领取1次,时间有限,记得及时参与~
近段时间经常有老师,私信小编,“某某指南无法下载,课程观看不了”此类问题经常出现!
原因是什么?
因为平台上一些学习资源,例如:指南、课程或者积分商场的礼品,需要消耗积分才可以参与,一些老师无法下载指南,观看课程主要是因为积分不足!
那么这个问题如何解决:
方法1:完成一些日常任务即可获得积分,例如完善个人信息,50积分,资讯文章评论,2积分,但这些积分获取速度可能太慢,满足不了老师们的学习需求。
方法2:参与【梅斯100积分限时领】活动
参与方法:
手机微信添加下方好友,即可立即领取,没有任何条件限制,参与即可得
活动每人仅限领取1次,时间有限,记得及时参与~

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2096264, encodeId=7e5f209626472, content=希望多多举办此类活动, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161227/IMG5861D3181499D5660.jpg, createdBy=db842001363, createdName=vu345, createdTime=Wed Oct 26 14:14:21 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095606, encodeId=67a720956062f, content=很好的活动! , beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57648392722, createdName=ms9000000115863138, createdTime=Sun Oct 23 20:24:40 CST 2022, time=2022-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248398, encodeId=dc411248398e1, content=很好的活动!, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09ca8319922, createdName=ms1000000163097122, createdTime=Sun Sep 11 16:43:26 CST 2022, time=2022-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235572, encodeId=2ab712355e250, content=获益很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b1f91479869, createdName=zmqlk, createdTime=Sat Jul 30 06:45:36 CST 2022, time=2022-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1277352, encodeId=a51212e7352f3, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sat Jul 23 02:05:46 CST 2022, time=2022-07-23, status=1, ipAttribution=)]
    2022-10-26 vu345

    希望多多举办此类活动

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2096264, encodeId=7e5f209626472, content=希望多多举办此类活动, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161227/IMG5861D3181499D5660.jpg, createdBy=db842001363, createdName=vu345, createdTime=Wed Oct 26 14:14:21 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095606, encodeId=67a720956062f, content=很好的活动! , beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57648392722, createdName=ms9000000115863138, createdTime=Sun Oct 23 20:24:40 CST 2022, time=2022-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248398, encodeId=dc411248398e1, content=很好的活动!, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09ca8319922, createdName=ms1000000163097122, createdTime=Sun Sep 11 16:43:26 CST 2022, time=2022-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235572, encodeId=2ab712355e250, content=获益很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b1f91479869, createdName=zmqlk, createdTime=Sat Jul 30 06:45:36 CST 2022, time=2022-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1277352, encodeId=a51212e7352f3, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sat Jul 23 02:05:46 CST 2022, time=2022-07-23, status=1, ipAttribution=)]
    2022-10-23 ms9000000115863138

    很好的活动!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2096264, encodeId=7e5f209626472, content=希望多多举办此类活动, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161227/IMG5861D3181499D5660.jpg, createdBy=db842001363, createdName=vu345, createdTime=Wed Oct 26 14:14:21 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095606, encodeId=67a720956062f, content=很好的活动! , beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57648392722, createdName=ms9000000115863138, createdTime=Sun Oct 23 20:24:40 CST 2022, time=2022-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248398, encodeId=dc411248398e1, content=很好的活动!, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09ca8319922, createdName=ms1000000163097122, createdTime=Sun Sep 11 16:43:26 CST 2022, time=2022-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235572, encodeId=2ab712355e250, content=获益很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b1f91479869, createdName=zmqlk, createdTime=Sat Jul 30 06:45:36 CST 2022, time=2022-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1277352, encodeId=a51212e7352f3, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sat Jul 23 02:05:46 CST 2022, time=2022-07-23, status=1, ipAttribution=)]
    2022-09-11 ms1000000163097122

    很好的活动!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2096264, encodeId=7e5f209626472, content=希望多多举办此类活动, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161227/IMG5861D3181499D5660.jpg, createdBy=db842001363, createdName=vu345, createdTime=Wed Oct 26 14:14:21 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095606, encodeId=67a720956062f, content=很好的活动! , beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57648392722, createdName=ms9000000115863138, createdTime=Sun Oct 23 20:24:40 CST 2022, time=2022-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248398, encodeId=dc411248398e1, content=很好的活动!, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09ca8319922, createdName=ms1000000163097122, createdTime=Sun Sep 11 16:43:26 CST 2022, time=2022-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235572, encodeId=2ab712355e250, content=获益很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b1f91479869, createdName=zmqlk, createdTime=Sat Jul 30 06:45:36 CST 2022, time=2022-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1277352, encodeId=a51212e7352f3, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sat Jul 23 02:05:46 CST 2022, time=2022-07-23, status=1, ipAttribution=)]
    2022-07-30 zmqlk

    获益很多

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2096264, encodeId=7e5f209626472, content=希望多多举办此类活动, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161227/IMG5861D3181499D5660.jpg, createdBy=db842001363, createdName=vu345, createdTime=Wed Oct 26 14:14:21 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095606, encodeId=67a720956062f, content=很好的活动! , beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57648392722, createdName=ms9000000115863138, createdTime=Sun Oct 23 20:24:40 CST 2022, time=2022-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248398, encodeId=dc411248398e1, content=很好的活动!, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09ca8319922, createdName=ms1000000163097122, createdTime=Sun Sep 11 16:43:26 CST 2022, time=2022-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1235572, encodeId=2ab712355e250, content=获益很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b1f91479869, createdName=zmqlk, createdTime=Sat Jul 30 06:45:36 CST 2022, time=2022-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1277352, encodeId=a51212e7352f3, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sat Jul 23 02:05:46 CST 2022, time=2022-07-23, status=1, ipAttribution=)]
    2022-07-23 一闲

相关资讯

羟氯喹与新冠:永无止尽的故事

在 COVID-19 大流行的早期,迫切需要一种治疗方法来对抗正在摧毁全球医疗保健系统的祸害。随着系统不堪重负,很明显需要有效、安全、可及的早期门诊治疗以防止恶化。

不止红斑狼疮!羟氯喹还可以治疗这些风湿病

细数羟氯喹在风湿免疫领域的使用。

A&R:造血PAD4在关节炎中的重要作用:胶原和粒细胞集落刺激因子诱导的C57BL/6小鼠关节炎模型

该研究团队成功开发了一种适用于C57BL/6小鼠的关节炎模型。该模型具有与人类RA一致的一些特征,表明造血PAD4是关节炎发展的重要贡献者。

不仅仅风湿免疫!羟氯喹在肿瘤领域也大显身手

肿瘤复发、化疗耐药和转移仍然是癌症治疗中未解决的问题。最近的一种方法是仔细检查临床上用于治疗其他疾病的药物,并修改它们的结构以增加对癌细胞的选择性。

“系统性红玟妊狼疮”眼中的羟氯喹

羟氯喹(HCQ)是一种用于治疗系统性红斑狼疮(SLE)和类风湿关节炎(RA)的改善疾病的抗风湿药物,与甲氨蝶呤和柳氮磺胺吡啶一起构成RA三联疗法的一部分。此外,HCQ还用于其他结缔组织疾病和皮肤病。

ARD:在巴西大量自身免疫性风湿病患者中接种第三剂同源灭活SARS-CoV-2疫苗后免疫原性增加

该研究提供了自身免疫性风湿病(ARD)患者对第三剂CoronaVac的强烈反应的新数据。除甲氨蝶呤(MTX)外,常规两剂方案后涉及降低免疫原性的药物与第三剂后无反应相关。